Evidence map›Paper›PMID 28700821›Full record

ArticleCancer2017

Gene expression profiling of prostate tissue identifies chromatin regulation as a potential link between obesity and lethal prostate cancer.

Ericka M Ebot, Travis Gerke, David P Labbé, Jennifer A Sinnott, Giorgia Zadra, Jennifer R Rider, Svitlana Tyekucheva, Kathryn M Wilson, Rachel S Kelly, Irene M Shui and 7 more

Open access · bronzeAbstract read
In one paragraph

Article in Cancer, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 19 citations in OpenAlex.

  1. Trial
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Statin Use Is Associated with Lower Risk of PTEN-Null and Lethal Prostate Cancer.Clinical cancer research : an official journal of the American Association for Cancer Research · 2020
    Article
  9. Obesity, height, and advanced prostate cancer: extending current evidence toward precision prevention.Annals of oncology : official journal of the European Society for Medical Oncology · 2020
    Article
  10. Article
  11. Clinical cancer research : an official journal of the American Association for Cancer Research · 2018
    Article
  12. Association of Anthropometric Measures with Prostate Cancer among African American Men in the NCI-Maryland Prostate Cancer Case-Control Study.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2018
    Article
  13. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors at 5 institutions in 2 countries.

Ericka M EbotDepartment of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, Massachusetts.ORCID http://orcid.org/0000-0001-7144-693X
Travis GerkeDepartment of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, Massachusetts.
David P LabbéDepartment of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.
Jennifer A SinnottDepartment of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, Massachusetts.
Giorgia ZadraDepartment of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.
Jennifer R RiderDepartment of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, Massachusetts.
Svitlana TyekuchevaDepartment of Biostatistics, Harvard T. H. Chan School of Public Health, Boston, Massachusetts.
Kathryn M WilsonDepartment of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, Massachusetts.
Rachel S KellyChanning Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
Irene M ShuiDepartment of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, Massachusetts.ORCID http://orcid.org/0000-0001-5737-9830
Massimo LodaDepartment of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.
Philip W KantoffDepartment of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
Stephen FinnDepartment of Histopathology, St. James's Hospital and Trinity College Dublin Medical School, Dublin, Ireland.
Matthew G Vander HeidenDepartment of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.
Myles BrownDepartment of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.
Edward L GiovannucciDepartment of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, Massachusetts.
Lorelei A MucciDepartment of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, Massachusetts.
Harvard University · USBrigham and Women's Hospital · USBoston University · USMemorial Sloan Kettering Cancer Center · USTrinity College Dublin · IE

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
Validity of Diet and Activity Measures in WomenP01CA055075 · NCI · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI RIMM, ERIC B · 1991 to 2009
$41.8M
Tumor and Circulating Markers as Links Between Obesity and Lethal Prostate CanceP50CA090381 · NCI · DANA-FARBER CANCER INSTITUTE · PI KANTOFF, PHILIP W · 2002 to 2017
$36.2M
Training Program in Cancer EpidemiologyT32CA009001 · NCI · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI A. Heather Eliassen, Meir Stampfer · 1985 to 2026
$17.3M
Cancer Epidemiology Cohort in Male Health ProfessionalsU01CA167552 · NCI · HARVARD UNIVERSITY D/B/A HARVARD SCHOOL OF PUBLIC HEALTH · PI Lorelei Mucci, Walter C. Willett · 2017 to 2026
$17.0M
Cancer Epidemiology Cohort in Male Health ProfessionalsUM1CA167552 · NCI · HARVARD SCHOOL OF PUBLIC HEALTH · PI WILLETT, WALTER C. · 2012 to 2016
$11.5M
Molecular Link Between Metabolic Syndrome and Prostate CancerR01CA131945 · NCI · DANA-FARBER CANCER INST · PI LODA, MASSIMO · 2008 to 2018
$4.0M
Energy Balance-Related Hormones & Prostate Cancer Incidence & ProgressionR01CA133891 · NCI · HARVARD SCHOOL OF PUBLIC HEALTH · PI GIOVANNUCCI, EDWARD · 2008 to 2012
$3.3M
Growth Factors and Lethal Prostate Cancer SignatureR01CA141298 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI STAMPFER, MEIR · 2010 to 2013
$2.2M
Sex-Hormones and the TMPRSS2: ERG Fusion in Prostate Cancer ProgressionR01CA136578 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI MUCCI, LORELEI · 2009 to 2013
$1.7M
Bioinformatics Tools for Genomic Analysis of Tumor and Stromal Pathways in CancerR01CA174206 · NCI · DANA-FARBER CANCER INST · PI PARMIGIANI, GIOVANNI LUIGI · 2013 to 2017
$1.7M
NCI NIH HHS P01 CA055075NCI NIH HHS P30 CA008748NCI NIH HHS P50 CA090381NCI NIH HHS R01 CA131945NCI NIH HHS R01 CA133891NCI NIH HHS R01 CA136578NCI NIH HHS R01 CA141298NCI NIH HHS R01 CA174206NCI NIH HHS T32 CA009001NCI NIH HHS U01 CA167552NCI NIH HHS UM1 CA167552
6 · The paper itself

Abstract

backgroundObese men are at higher risk of advanced prostate cancer and cancer-specific mortality; however, the biology underlying this association remains unclear. This study examined gene expression profiles of prostate tissue to identify biological processes differentially expressed by obesity status and lethal prostate cancer.

methodsGene expression profiling was performed on tumor (n = 402) and adjacent normal (n = 200) prostate tissue from participants in 2 prospective cohorts who had been diagnosed with prostate cancer from 1982 to 2005. Body mass index (BMI) was calculated from the questionnaire immediately preceding cancer diagnosis. Men were followed for metastases or prostate cancer-specific death (lethal disease) through 2011. Gene Ontology biological processes differentially expressed by BMI were identified using gene set enrichment analysis. Pathway scores were computed by averaging the signal intensities of member genes. Odds ratios (ORs) for lethal prostate cancer were estimated with logistic regression.

resultsAmong 402 men, 48% were healthy weight, 31% were overweight, and 21% were very overweight/obese. Fifteen gene sets were enriched in tumor tissue, but not normal tissue, of very overweight/obese men versus healthy-weight men; 5 of these were related to chromatin modification and remodeling (false-discovery rate < 0.25). Patients with high tumor expression of chromatin-related genes had worse clinical characteristics (Gleason grade > 7, 41% vs 17%; P = 2 × 10

conclusionsThis study improves our understanding of the biology of aggressive prostate cancer and identifies a potential mechanistic link between obesity and prostate cancer death that warrants further study. Cancer 2017;123:4130-4138. © 2017 American Cancer Society.

Indexed as

Gene Expression ProfilingAgedBody Mass IndexChromatinHumansLogistic ModelsMaleMiddle AgedObesityOdds RatioOverweightProspective StudiesProstateProstatic NeoplasmsChromatinbody mass indexchromatin modificationchromatin remodelinggene expressionobesityprostate cancerprostate cancer-specific mortality

Identifiers

PMID28700821
PMCPMC5802874
OpenAlexW2736186231

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.